pregnancy on glp 1 GLP-1 drugs and pregnancy: Why stopping may trigger hidden risks | Health News Drugstore Frontiers | GLP-1 based Size:1 Pack

pregnancy on glp 1 GLP-1 drugs and pregnancy: Why stopping may trigger hidden risks | Health News Drugstore Frontiers | GLP-1 based Size:1 Pack

Frontiers | GLP-1 based therapeutics: simultaneously combating T2DM and obesity

95% CI 0.457–0.77), acute heart failure (HR 0.496), angina (HR 0.566), and stroke (HR 0.661), with no increase in myocardial infarction or arrhythmias [36]

Drugstore

Size:1 Pack

Nevertheless, it is crucial to consider the potential adverse effects of weight fluctuation after discontinuing these medications, particularly the increased risk of cardiovascular and all-cause mortality in patients with obesity or overweight